Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 63.24M | 57.72M | 53.67M | 50.38M | 37.86M | 31.81M |
Gross Profit | 56.29M | 51.76M | 48.59M | 46.10M | 34.13M | 30.32M |
EBITDA | -24.45M | -24.83M | -28.52M | -25.35M | -20.27M | -1.25M |
Net Income | -33.14M | -33.64M | -36.87M | -27.10M | -23.38M | -3.26M |
Balance Sheet | ||||||
Total Assets | 106.88M | 106.14M | 102.80M | 115.52M | 120.44M | 42.74M |
Cash, Cash Equivalents and Short-Term Investments | 38.05M | 43.84M | 41.17M | 68.15M | 85.83M | 11.74M |
Total Debt | 7.36M | 5.99M | 7.75M | 3.62M | 3.91M | 4.77M |
Total Liabilities | 114.41M | 107.32M | 87.70M | 77.98M | 67.54M | 54.74M |
Stockholders Equity | -7.53M | -1.19M | 15.10M | 37.53M | 52.90M | -12.01M |
Cash Flow | ||||||
Free Cash Flow | -1.75M | -1.04M | -17.23M | -7.82M | -1.62M | 1.51M |
Operating Cash Flow | -1.13M | -720.00K | -15.73M | -6.77M | -814.00K | 2.16M |
Investing Cash Flow | -5.99M | 970.00K | -4.69M | -37.48M | -1.36M | -5.15M |
Financing Cash Flow | 1.09M | -262.00K | -2.92M | -4.15M | 76.25M | 790.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | $306.43M | 21.08 | 23.09% | 6.31% | -9.22% | -13.57% | |
61 Neutral | $36.30B | 7.26 | -7.27% | 1.97% | 7.74% | -7.92% | |
59 Neutral | $564.20M | 19.55 | -3.34% | ― | -10.95% | -111.40% | |
56 Neutral | $1.01B | ― | -36.20% | ― | -7.49% | -64.33% | |
51 Neutral | $404.32M | ― | -1369.57% | ― | 18.64% | 16.54% | |
49 Neutral | $272.47M | ― | -0.92% | ― | -6.09% | 97.33% | |
46 Neutral | $384.36M | ― | -1405.64% | ― | ― | -10774.57% |
On June 3, 2025, Arteris, Inc. held its Annual Meeting of Stockholders where two key proposals were voted upon. The stockholders elected two Class I directors, K. Charles Janac and S. Atiq Raza, to serve until the 2028 annual meeting, and ratified Deloitte & Touche, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (AIP) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Arteris stock, see the AIP Stock Forecast page.